Proliferative activity of early ovarian clear cell adenocarcinoma depends on association with endometriosis

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 127, Issue 1, 2006, Pages 130-136

  Komiyama, Shin ichi ^a,b   Aoki, Daisuke ^a   Katsuki, Yukio ^c   Nozawa, Shiro ^a  

^a KEIO UNIVERSITY   (Japan)

^b SAITAMA NATIONAL HOSPITAL   (Japan)

^c MOCHIDA PHARMACEUTICAL CO   (Japan)

Author keywords

Bromodeoxyuridine; Endometriosis; Ovarian clear cell adenocarcinoma; Proliferating cell nuclear antigen; SCID mouse; Stage I; Transforming growth factor beta 1; Xenograft

Indexed keywords

BROXURIDINE; CYCLINE; CYTOKINE; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CANCER PATIENT; CANCER TISSUE; CELL PROLIFERATION; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENDOMETRIOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MOUSE; NONHUMAN; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SCID MOUSE; TUMOR XENOGRAFT;

EID: 33745420948     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2005.11.030     Document Type: Article

References (44)

1. Scully R.E., Young R.H., and Clement P.B. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. In: Rosai J. (Ed). Atlas of tumor pathology, 3rd series (1996), Armed Forces Institute of Pathology, Washington, D.C. 141-151
2. Russel P. Surface epithelial-stromal tumor of the ovary. In: Kurman R.J. (Ed). Blaustein's pathology of the female genital tract. 4th ed. (1995), Springer-Verlag, New York 752-762
3. Scully R.E., and Barlos J.F. "Mesonephroma" of the ovary: tumor of the Mullerian nature related to endometrioid carcinoma. Cancer 20 (1967) 1405-1417
4. Aure J.C., Hoeg K., and Kolstad P. Carcinoma of the ovary and endometriosis. Acta Obstet Gynecol Scand 50 (1971) 63-67
5. Kurman R.E., and Craig J.M. Endometrioid and clear cell carcinoma of the ovary. Cancer 20 (1972) 1653-1664
6. Mostoufizadeh M., and Scully R.E. Malignant tumor arising in endometriosis. Clin Obstet Gynecol 23 (1980) 951-963
7. Montag A.G., Jenison E.L., Griffiths C.T., Welch W.R., Lavin P.T., and Knapp R.C. Ovarian clear cell carcinoma. A clinicopathologic analysis of 44 cases. Int J Gynecol Pathol 8 (1989) 85-96
8. Vercellini P., Parazzini F., Bolis G., et al. Endometriosis and ovarian cancer. Am J Obstet Gynecol 169 (1993) 181-182
9. Cuesta R.S., Eichhorn J.H., Rice L.W., Fuller A.F., Nikrui N., and Goff A.G. Histologic transformation of benign endometriosis to early epithelial ovarian cancer. Gynecol Oncol 60 (1996) 238-244
10. Goff B.A., Sainz de la Cuesta R., Muntz H.G., et al. Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol 60 (1996) 412-417
11. Modesitt S.C., Tortolero-Luna G., Robinson J.B., Gershenson D.M., and Wolf J.K. Ovarian and extraovarian endometriosis-associated cancer. Obstet Gynecol 100 (2002) 788-795
12. Komiyama S., Aoki D., Udagawa Y., et al. A study on ovarian clear cell carcinoma associated with pelvic endometriosis. Int J Gynecol Cancer 7 (1997) 78
13. Komiyama S., Aoki D., Tominaga E., Susumu N., Udagawa Y., and Nozawa S. Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation. Gynecol Oncol 72 (1999) 342-346
14. Crozier M.A., Copeland L.J., Silva E.G., Gershenson D.M., and Stringer C.A. Clear cell carcinoma of the ovary: a study of 59 cases. Gynecol Oncol 35 (1989) 199-203
15. O'Brien M.E.R., Schofield J.B., and Tan S. Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages. Gynecol Oncol 49 (1993) 250-254
16. Behbakht K., Randall T.C., Benjamin I., Morgan M.A., King S., and Rubin S.C. Clinical characteristics of clear cell carcinoma of the ovary. Gynecol Oncol 70 (1998) 255-258
17. Kennedy A.W., Markman M., Biscotti C.V., Emery J.D., and Rybicki L.A. Survival probability in ovarian clear cell adenocarcinoma. Gynecol Oncol 74 (1999) 108-114
18. Sugiyama T., Kamura T., Kigawa J., et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 88 (2000) 2584-2589
19. Sakuragi N., Yamada H., Oikawa M., et al. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0). Gynecol Oncol 79 (2000) 251-255
20. Kita T., Kikuchi Y., Kudoh K., et al. Exploratory study of effective chemotherapy for clear cell carcinoma of the ovary. Oncol Rep 7 (2000) 327-331
21. Jimbo H., Yoshikawa H., Onda T., Yasugi T., Sakamoto A., and Taketani Y. Prevalence of ovarian endometriosis in epithelial ovarian cancer. Int J Gynecol Obstet 59 (1997) 245-250
22. Fukunaga M., Nomura K., Ishikawa E., and Ushigome S. Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology 30 (1997) 249-255
23. Erzen M., Rakar S., Klancnik B., Syrjanen K., and Klancar B. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study. Gynecol Oncol 83 (2001) 100-108
24. Nozawa S., Tsukazaki K., Sakayori M., Jeng C.H., and Iizuka R. Establishment of a human ovarian clear cell carcinoma cell line (RMG-I) and its single cell cloning with special reference to the stem cell of the tumor. Hum Cell 1 (1988) 426-435
25. Aoki D., Katsuki Y., Shimizu A., Kakinuma C., and Nozawa S. Successful heterotransplantation of human endometrium in SCID mice. Obstet Gynecol 83 (1994) 220-228
26. Kamel O.W., Brun D.P., Davis R.E., Berry G.J., and Warnke R.A. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA cyclin 19A2. Correlation with Ki-67 labeling. Am J Pathol 138 (1991) 1471-1477
27. Louis D.N., Edgerton S., Thor A.D., and Hedley E.T. Proliferative cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: a comparative study. Acta Neuropathol (Berl) 81 (1991) 675-679
28. Xiong Y., Zhang H., and Beach D. D type cyclin associates with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71 (1992) 505-514
29. Hall P.A., Levison D.A., Woods A.L., et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162 (1990) 285-294
30. Dawson A.E., Norton J.A., and Weinberg D.S. Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry. Am J Pathol 136 (1990) 1115-1124
31. Lipponen P.K., and Eskelin M.J. Cell proliferation of transitional cell bladder tumors determined by PCNA/cyclin immunostaining and its prognostic value. Br J Cancer 66 (1992) 171-176
32. Oka K., Hoshi T., and Arai T. Prognostic significance of the PC10 index as a prospective assay for cervical cancer treated with radiation therapy alone. Cancer 70 (1992) 1545-1550
33. Rosa J.C., Mendes R., Filipe M.I., and Morris R.W. Measurement of cell proliferation in gastric carcinoma: comparative analysis of Ki-67 and proliferating cell nuclear antigen (PCNA). Histochem J 24 (1992) 93-101
34. Thomas H., Nasim M.M., Sarraf C.E., et al. Proliferating cell nuclear antigen (PCNA) immunostaining-a prognostic factor in ovarian cancer?. Br J Cancer 71 (1995) 357-362
35. Wassen N.H., and Lane D.P. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA): structural conversation and detection of a nuclear form. J Cell Sci 96 (1990) 121-129
36. Oosterlynck D.J., Meuleman C., Waer M., and Koninckx P.R. Transforming growth factor-β activity is increased in peritoneal fluid from women with endometriosis. Obstet Gynecol 83 (1994) 287-292
37. Whitworth C.M., Mulholland J., Dunn R.C., and Glasser S.R. Growth factor effects on endometriotial epithelial cell differentiation and protein synthesis in vitro. Fertil Steril 61 (1994) 91-96
38. Badawy S.Z., Cuenca V., Kumar S., and Holland J. Effect of chocolate cyst fluid on endometriomal cell growth in culture. Fertil Steril 70 (1998) 827-830
39. Terakawa N., and Harada T. Effect of medical treatment on active lesions of peritoneal endometriosis. In: Minaguchi H. (Ed). Endometriosis today (1997), The Parthenon Publishing Group, London 329-333
40. Kupker W., Schultze-Mosgau A., and Diedrich K. Paracrine changes in the peritoneal environment of women with endometriosis. Hum Reprod Update 4 (1998) 719-723
41. Rier S.E., Parsons A.K., and Becker J.L. Altered interleukin-6 production by peritoneal leukocytes from patients with endometriosis. Fertil Steril 61 (1994) 294-299
42. Punnonen J., Teisala K., Ranta H., Bennett B., and Punnonen R. Increased levels of interleukin-6 and interleukin-10 in the peritoneal fluid of patients with endometriosis. Am J Obstet Gynecol 174 (1996) 1522-1526
43. Moses H.L., Yang E.Y., and Pietenpol J.A. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63 (1990) 245-247
44. In: Sporn M.B., and Roberts A.B. (Eds). Peptide growth factors and their receptors, part I & II (1990), Springer-Verlag, Berlin